Providing efficient encapsulation and solubilization solutions for chemotherapy molecules with poor water solubility but high efficacy.
Targeted Drug Delivery for Chemotherapy
Creative Biolabs specializes in applying advanced targeted drug delivery systems (TDDS) to therapeutics. We partner with clients to fundamentally re-engineer chemotherapy pharmacokinetics, solving the chronic problems of systemic toxicity and low therapeutic efficacy. Our goal is to transform your promising drug compound into a highly optimized, site-specific medicine ready for clinical success.
What is Targeted Delivery?
Targeted Drug Delivery Systems utilize nanocarriers, typically ranging from 10 to 100 nm, to package and protect cytotoxic agents. These nanoscale vehicles redirect the therapeutic payload to the precise site of disease, rather than distributing it throughout the body. By leveraging tumor-specific characteristics—such as leaky vasculature and overexpressed receptors—TDDS ensures that a significantly higher concentration of the drug accumulates only where it is needed. This precision approach is the defining feature of next-generation chemotherapy.
Applications for Chemotherapy
Targeted delivery services provide crucial support for various chemotherapy drugs and treatment strategies, with a particular focus on addressing delivery challenges in the following areas:
Novel/Poorly Soluble Agents
Oncology Combination Therapy
Achieving synergistic co-delivery of two or more drugs (e.g., chemotherapy drugs + targeted therapies/immunomodulators) to optimize pharmacokinetics and efficacy.
Drug-Resistant Tumors
Designing delivery systems capable of bypassing multidrug resistance (MDR) mechanisms to restore tumor cell sensitivity to chemotherapy drugs.
Regional/Localized Chemotherapy
Developing sustained-release formulations for local administration, such as intraperitoneal, bladder, or arterial embolization, to maximize local efficacy and minimize systemic exposure.
Delivery Challenges of Traditional Chemotherapy
The limitations of traditional, non-specific chemotherapy are well-documented and must be overcome to improve patient outcomes. Targeted delivery provides the only way to achieve a "precision strike" in the fight against cancer.
Non-specific drug distribution damages healthy, rapidly dividing tissues such as bone marrow, hair follicles, heart muscle, and kidneys, leading to severe side effects and strictly limiting the maximum tolerated dose (MTD) a patient can receive.
Fig.1 Mechanism of MDR and its reversal on treatment with NP-drug conjugates.1
What We Can Offer
Creative Biolabs offers proprietary, end-to-end solutions to overcome these delivery hurdles, transforming the safety profile and efficacy of your therapeutic agent.
High-Load Nanoparticle Formulation Development
We utilize advanced microfluidics to achieve precise nano-sizing and efficient encapsulation of poorly soluble chemotherapy drugs. This significantly improves drug water solubility and systemic bioavailability. Our proven platforms include highly stable liposomes, polymer nanomicelles, and sophisticated inorganic nanocarriers.
Intelligent Response Delivery Systems
We specialize in developing carriers sensitive to the tumor microenvironment (e.g., low pH linkers, high reduction potential bonds, specific enzyme-cleavable sites). These systems guarantee highly specific and often "explosive" drug release precisely at the tumor site, maximizing local concentration and minimizing off-target exposure.
Active Targeted Modification & Combination Therapy
Our chemistry team leverages robust conjugation techniques (like click chemistry) to link active targeting ligands (such as peptides and antibody fragments). This achieves precise recognition of tumor-specific receptors, significantly enhancing tumor enrichment. Furthermore, we support the co-delivery of chemotherapy drugs with targeted agents or immunomodulators for true Combination Therapy.
Why Choose Us?
Integrated Expertise
We combine high-level chemical engineering and formulation science with deep biological understanding of the tumor microenvironment (TME) for holistic solution design.
Customized Roadmaps
We never provide off-the-shelf solutions. Instead, we develop customized, de-risked delivery roadmaps tailored to the unique physicochemical properties of your drug compound.
Cutting-Edge Technology
Our commitment includes the development of advanced systems, such as Biomimetic Carriers (e.g., cell-membrane-coated nanocarriers), to enhance immune evasion and targeting efficiency.
Scalability & Viability
We prioritize the mastery of scalable, compliant manufacturing processes to ensure your next-generation targeted chemotherapy formulation is stable, clinically viable, and ready for commercialization.
Workflow
Make your chemotherapy drugs safer and more effective! Don't let toxicity and drug resistance limit the potential of your drugs. Please contact our team of chemotherapy delivery experts to begin customizing your next-generation targeted chemotherapy formulation.
Reference
- Tiwari, Harshita, et al. "Recent advances in nanomaterials-based targeted drug delivery for preclinical cancer diagnosis and therapeutics." Bioengineering 10.7 (2023): 760. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/bioengineering10070760.
Our services are For Research Use Only. We do not provide services to individuals.
Online Inquiry
